POL6014, ein hochpotenter inhalativer Inhibitor der humanen Neutrophilen Elastase mit vielversprechenden ersten Studienergebnissen in Mukoviszidose-Patienten | 20th Annual Meeting Muko e.V. - Nov 16 - 18, 2017 - Würzburg
Conducting global studies with a flexible network of specialized CROs: How can we achieve Process Standardization & Remain Flexible to achieve Milestones? | Canada Talks Pharma 2016 - May 27, 2016
Safety and tolerability of a novel inhaled GATA3 mRNA targeting DNAzyme in patients with TH2-driven asthma. Letter to the Editor. | Journal of Allergy and Clinical Immunology (JACI). Published Online: April 01, 2015.
Most common clinical pharmacology trials: FIM, safety, exploratory PK and PD, PoC trials, drug-drug-interaction, drug-food interaction, bioavailability, bioequivalence, QTc trial, adaptive designs, basic concepts of clinical development planning | Lecture at the Introductory Course in Translational Medicine / Applied Human Pharmacology – Part I Arbeitsgemeinschaft für angewandte Humanpharmakologie [Association for Applied Human Pharmacology] (AGAH e.V.), Feb 18, 2015, Frankfurt
Design elements of human pharmacology trials | Lecture at the Introductory Course in Translational Medicine / Applied Human Pharmacology – Part I Arbeitsgemeinschaft für angewandte Humanpharmakologie [Association for Applied Human Pharmacology] (AGAH e.V.), Feb 17, 2015, Frankfurt